257: Cardiovascular risk prevalence in high risk primary care patients not treated with lipid-lowering treatment in France, results of an online study

Purpose Few data exists on high cardiovascular risk (HCVR) prevalence within a primary prevention population. The goal of the study was to assess HCVR distribution, according to SCORE, in France for high-risk primary care patients not treated with lipid-lowering drug. Methods This observational study was conducted over a week on a representative sample of French general practitioners (GP). All consulting primary care men/women ≥50/60 y, with at least one other CVR factor (smoking, high blood pressure (HBP), type 2 diabetes, HDL-c Results GPs (n=1147) included 9049 patients with the following characteristics: mean age: 68 y; male: 57%; LDLc>1.3 g/L: 57%; smoking: 21%; HBP: 44%; type 2 diabetes: 21% HDL-c According to SCORE, HCVR prevalence reached 50% in total population (male: 49%, female: 51%). 50% of HCVR men/women were older than >72.4/78.8 y. HCVR patients were older by 7.7/6.8 y for male/female (p Conclusions Half consulting primary care patients aged ≥50/60 y for men/women with at least 1 risk factor on top of age and no lipid-lowering treatment are at HCVR according to SCORE risk equation. Assessing cardiovascular risk with risk equations appears particularly useful in this group of patients. Besides age, which has the strongest impact on risk estimation, other RF may be screened to improve HCVR management.